Senior insider sale
Chief Scientific Officer at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$8.3K
13.32K shares
What this filing means
LOWINGER TIMOTHY B plans to sell 13.32K shares of MERSANA THERAPEUTICS, INC. valued at approximately $8.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/17/2025ACC: 0001104659-25-004585
Officer· Chief Scientific Officer
Since Jul 2018
13.32K
Shares to sell
$8.3K
Approx. market value
19.79K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Vesting of restricted stock unit grant
Services rendered
1/15/2025
7.29KVesting of restricted stock unit grant
Services rendered
1/15/2025
12.50KTotal acquired19.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2025 | Vesting of restricted stock unit grant Services rendered | 7.29K | — |
1/15/2025 | Vesting of restricted stock unit grant Services rendered | 12.50K | — |
| Total | 19.79K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.79K
Market value
$1.1K
1/15/2025
—Completed
Units to sell
3.48K
Market value
$2.3K
1/14/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.05K
Market value
$4.9K
1/16/2025
Total
Units
13.32K
Value
$8.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/15/2025 | 1.79K | $1.1K | — | Completed |
1/14/2025 | 3.48K | $2.3K | — | Completed |
| Planned — Approximate Date | ||||
1/16/2025 | 8.05K | $4.9K | NASDAQ | Planned |
| Total | 13.32K | $8.3K | ||